# Benitec Biopharma Inc.: Form 8-K, filed Jul 25, 2023

- Company: [Benitec Biopharma Inc.](/companies/bntc.md) (CIK 1808898)
- Form: 8-K
- Filed: 2023-07-25
- Accepted by EDGAR: Jul 25, 2023, 14:08 ET
- Period: 2023-07-25
- Accession: 0001193125-23-193295
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1808898/000119312523193295/d512923d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1808898/000119312523193295/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1808898/000119312523193295/d512923d8k.htm

Filed Jul 25, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-193295. Last ingested by Listed: Nov 14, 2026, 11:28 ET. No prices; not investment advice.
